¶¶ |
Reporting Data Item |
Business Justification |
Definition Note: Where ‘NHS Wales Data Dictionary’ the definition is as per the Data Dictionary. |
Permissible Values |
11. CLINICAL STATUS ASSESSMENT | ||||
11.0 ENCDv4.5b (15.1)
SPCDv1.0 (9.1) |
Death date |
To determine survival rates and mortality rates. |
Date of patient’s death. |
NHS Wales Data Dictionary
|
11.1 NLCA |
Toxicity of complications at clinical status assessment |
To determine patterns of adverse events associated with a treatment. Required for submission to the national lung cancer audit. |
Diagnosis of complications at clinical status assessment. Any morbidity, relevant to previous chemotherapy or radiotherapy treatments that the patient has received, recorded at any subsequent patient contact. |
Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review.
For Chemotherapy (only long term adverse effects need to be reported) •Moderate toxicity •Severe toxicity •Death due to toxicity
For Radiotherapy (only significant morbidity needs to be reported): •Moderate toxicity •Severe toxicity •Death due to toxicity |